Kim Kardashian, Chelsea Handler Popularized 'Miracle' Weight Loss Drug Ozempic — Now Its Seeing A Surge Of Interest In The UK

The weight-loss drug Ozempic, popularized in the U.S. by celebrities such as Kim Kardashian and Chelsea Handler, is being eyed with concern in the U.K. due to its off-label use and potential side effects, iNews reports.

Off-Label Use and Potential UK Impact

The surge in Ozempic’s popularity in the U.S., originally prescribed for type 2 diabetes, has led to shortages and raised concerns about its off-label use for weight loss. The U.S. Food and Drug Administration (FDA) has stated that any use of Ozempic outside of diabetes treatment would be considered ‘off-label’ use, a situation that could potentially replicate in the U.K..

See Also: Novo Nordisk’s Weight Loss Medications Under European Investigation Over Suicidal Risks Amid High Demand

Obesity: A Chronic Disease

With 28% of adults in England suffering from obesity, according to the Centre for Disease Control, the use of drugs like Ozempic could increase. Dr. Delilah Strother, a family doctor in Seattle, emphasized that “Obesity is a chronic hormonal disease, not a lack of willpower,” suggesting the need for effective medications.

Popularity and Potential Side Effects

Ozempic’s popularity has skyrocketed in the U.S., with demand reaching a high in February 2023 when doctors filled 373,000 prescriptions in one week alone. However, experts have warned of potential side effects, including ‘Ozempic face,’ a result of rapid weight loss, a concern that could extend to U.K. users.

Read Next: Miracle Weight Loss Drug Ozempic Linked To Thyroid Cancer, Regulator Warns

Image via Shutterstock

Benzinga Newsbot

Hi, I am the Benzinga Newsbot! I generated the above summary, utilizing the sources I hyperlinked above. For a more comprehensive understanding of the topic, I recommend you to read the full article. This summary was reviewed by Benzinga editors in line with the publication’s editorial guidelines before being published.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareMediaGeneralDiabetesOzempicUKWeight Loss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!